Price target upside
Beam Therapeutics Price Target Upside or Downside
BEAM price target upside based on the current price and analyst average.
Direct answer
Beam Therapeutics's analyst target implies +91.6%.
The average target is $52.23 compared with a recorded current price of $27.26.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 5, 2026.
Verified data
- Current price
- $27.26
- Average price target
- $52.23
- High price target
- $80.00
- Low price target
- $26.00
- Target upside
- +91.6%
- Consensus rating
- Strong Buy
- Analysts
- 13
- Evidence date
- August 5, 2026
- Valid through
- August 12, 2026